Diarrhea Articles & Analysis
57 news found
Global Handwashing Day is an international advocacy that emphasizes the importance of washing hands with water and soap as a simple yet effective way to prevent illnesses such as diarrhea and pneumonia. Celebrated every October, GHD is observed in over 1 million schools across 100 countries, engaging more than 200 million people worldwide. ...
According to the Centers for Disease Control and Prevention (CDC), it is the leading cause of vomiting and diarrhea, and foodborne illness in the United States. The agency also warns that infection with one type of norovirus may not protect an individual against other types. ...
The most frequent treatment-emergent adverse events (AEs) determined to be possibly related to tulmimetostat included thrombocytopenia (47.1%), diarrhea (37.3%), nausea (29.4%), anemia (27.5%), fatigue (25.5%), neutropenia (17.6%), dysgeusia (17.6%), alopecia (15.7%) and vomiting (15.7%). ...
The most common (≥25%) nonhematologic treatment-emergent AEs of any grade were diarrhea (43%), respiratory tract infection (41%), asthenic conditions (38%), musculoskeletal pain (32%), constipation (30%), nausea (29%), dizziness (27%) and abdominal pain (26%). ...
Lumen's clinical pipeline includes investigational biologic drugs for C. difficile infection, Covid-19, cardiometabolic disease, inflammatory bowel disease, norovirus, and traveler's diarrhea. ...
Common TEAEs (>5% in the zuranolone 50 mg arm) were somnolence, dizziness, sedation, headache, diarrhea, nausea, urinary tract infection and COVID-19. Sage Therapeutics and Biogen have initiated a rolling submission of a New Drug Application (NDA) to the U.S. ...
The most common (≥20%) adverse reactions were nail toxicity, musculoskeletal pain, constipation, diarrhea, fatigue, dry mouth, alopecia, stomatitis, dry skin, arthralgia, dysgeusia, abdominal pain, dry eye, nausea, decreased appetite, urinary tract infection, palmar-plantar erythrodysesthesia syndrome, and vomiting. ...
His entire body became inflamed and swollen, his skin stretched so tightly that his blood was visible beneath his skin, like magma bubbling at a crack in the Earth’s surface. He suffered severe diarrhea and multiple heart attacks until, one by one, his organs began to shut down. ...
The most common treatment-related adverse events (TRAEs) were hyperphosphatemia (85%), alopecia (33%), dry mouth (30%), diarrhea (28%), dry skin (27%) and fatigue (25%). Most TRAEs were of mild or moderate intensity and manageable. ...
Narazaciclib’s inhibitory activity against GSK3β, a kinase whose inhibition putatively causes tolerability issues related to diarrhea, is ~29 times less than that of abemaciclib. Cellular kinase assays showed narazaciclib’s highest inhibitory activity to be against CDK4/6, CSF1R, (supports pro-tumor immune suppression), and NUAK1/ARK 5 (associated with poor ...
Digestive symptoms further include bouts of nausea and vomiting. Abdominal pain and episodic diarrhea may also be observed. Swelling of lips, tongue, and other parts of the body, and eczema, rashes and hives are very common signs of developing an allergy. ...
During relapses, acute inflammation occurs in the bowel of IBD patients, leading to typical symptoms such as chronic diarrhea, abdominal pain, and/or weight loss. However, these symptoms are not specific to IBD, but can also be caused, for example, by irritable bowel syndrome (IBS). ...
THOUSAND OAKS, Calif., May 12, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Otezla® (apremilast) have partnered with pop icon and entrepreneur Lance Bass, for the Double Take campaign to empower people to take action when it comes to psoriatic arthritis. As a singer, dancer and entertainer, Bass understands the importance of staying in tune with your body. Through the campaign, he has created ...
The most common side effects reported in more than 5% of patients are diarrhea, nausea, and headache. To learn more about Bass' story, the Double Take dance, and the signs and symptoms of psoriatic arthritis, visit ...
The most frequently reported events were: hypertension: 1 (n=7); diarrhea: 1.0% (n=4); injection site reaction: 0.5% (n=2), and headache: 0.5% (n=2). ...
Most common adverse reactions observed in clinical trials (incidence ≥2%) were vulvovaginal candidiasis, headache, nausea, dysgeusia, vomiting, diarrhea, abdominal pain, and vulvovaginal pruritus. To report SUSPECTED ADVERSE REACTIONS, contact Lupin Pharmaceuticals, Inc. at 1-844-SOLOSEC (1-844-765-6732) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. ...
ADVERSE REACTIONS The most common (≥20%) adverse reactions were fatigue, hypertension, diarrhea, decreased appetite, nausea, dysphonia, hypothyroidism, cough, and stomatitis, and the most common Grade 3 or 4 laboratory abnormalities (≥5%) were sodium decreased, lipase increased, and phosphate decreased. ...
In the nine treated subjects, there have been no device- or procedure-related Serious Adverse Events (SAEs) and no AESI (such as nausea, vomiting, or diarrhea, as defined in conjunction with the FDA). One subject who did not tolerate empagliflozin therapy withdrew from the study for reasons that were not related to Revita. ...
Adverse Reactions The most common adverse reactions (incidence ≥2% and ≥1% higher than placebo) were diarrhea (9.0%), dizziness (6.8%), nausea (6.6%), gait disturbances, including falls (6.6%), hyperkalemia (4.7%), headache (4.5%), somnolence (4.2%), and mental status changes (3.3%). ...
ADVERSE REACTIONS The most common (≥20%) adverse reactions were fatigue, hypertension, diarrhea, decreased appetite, nausea, dysphonia, hypothyroidism, cough, and stomatitis, and the most common Grade 3 or 4 laboratory abnormalities (≥5%) were sodium decreased, lipase increased, and phosphate decreased. ...